Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05737537

Using of Biomarkers and Blood Culture in Early Detection of Systemic Infections

Conditions: Invasive Fungal Infections

Sex: All
Ages: N/A – 18 Years
Phase: NA
Enrollment: 90
Sponsor: Assiut University

Summary

This work aims to:Validate the performance of CRP, and PCT in early differentiating IFI from bacterial bloodstream infections.Compare the results of CRP and PCT with the results of β-D- glucan. 3. Find the relationship between biomarkers levels [CRP, PCT and β-D- glucan] and the results of blood culture which is the gold standard of diagnosis.

Eligibility Criteria

Inclusion Criteria:Patients clinically suspected to have invasive fungal infections such as fever, cough or retrosternal pain, oral mucositis or perianal pain.Drug history of corticosteroids or chemotherapy.Exclusion Criteria:Patients refuse to be part of the study.Patients have no symptoms of systemic infections.Drug history for antimicrobial before blood sample collection.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05737537). StuddyBuddy aggregates publicly available trial information.